HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. It provides Fruquintinib, a selective and potent oral...
30 insider purchases on record · latest filing 2007-08-30.
Insiders have also filed 7 sale transactions at HCM.